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Background: To investigate effects of falciparum malaria on circulating levels of leptin and
adiponectin in type 2 diabetes mellitus (T2DM) and non-diabetic controls in relation to
measures of adiposity.
Methods: Levels of leptin and adiponectin were measured in 100 type 2 diabetics and 100
age-matched controls before and during falciparum malaria in a 2-year prospective study.
Also, waist circumference (WC), weight, height and hip circumference were measured.
Body mass index (BMI) and waist-to-hip ratio (WHR) were computed.
Results: At baseline, diabetics had significantly (p < 0.05) higher WC and BMI but lower
WHR, leptin and adiponectin levels. Baseline leptin correlated positively with WC
(r ¼ 0.633; p < 0.001) and BMI (r ¼ 0.63; p < 0.001) in diabetics but only BMI (0.562; p < 0.001) in
non-diabetic controls. Baseline leptin and adiponectin correlated positively (r ¼ 0.249;
p ¼ 0.029) in non-diabetic respondents only. Adiponectin correlated negatively with WC
(r ¼ 0.58; p ¼ 0.006) in diabetic males only. During malaria, mean levels of leptin and
adiponectin were comparable (p > 0.05) between diabetics and controls. However,
compared to baseline levels, significant (p < 0.001) elevation of adiponectin was found in
both study groups. In respect of leptin, significant (p < 0.001) rise but decline was observed
in diabetics and controls respectively. Malaria-induced leptin correlated negatively with
adiponectin (r ¼ 0.694; p < 0.001) in non-diabetic controls only.
Conclusion: Diabetics and controls exhibited increased adiponectin levels due to falciparum
malaria but differed in response in terms of leptin levels.ical Biochemistry, Schoo
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At a glance commentary
Scientific background on the subject
Little is known regarding how leptin and adiponectin
respond to infectious agents. With sub-Saharan Africa
shouldering over 80% of global malaria burden and pre-
dicted to accommodate the highest burden of T2DM by
2030, investigating the response of these adipocytokines
to malaria and implications of its interaction with T2DM
is paramount.
What this study adds to the field
Falciparum malaria increased cardiovascular disease
(CVD) risk of diabetics and non-diabetic controls through
elevation of adiponectin levels independent of adiposity.
In terms of leptin, elevation and reduction in levels were
observed in diabetics and control respondents respec-
tively suggesting different mechanisms for malaria-
induced CVD risk in the study groups.
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condition still affects millions of people in the world [1]. In the
case of type 2 diabetes mellitus (T2DM), a recent International
Diabetes Federation (IDF) report suggests continued elevation
of incidence of the disease across the various continents of the
globe [2]. In both conditions, sub-Saharan Africa contributes
over 80% to the reported cases globally, suggesting a possible
inevitable coexistence of malaria and T2DM in the same in-
dividual; a situation thatmay pose additional health challenge
that ought to be investigated. Leptin and adiponectin are
important adipocytokines that have been mostly associated
with T2DM and other chronic non-communicable diseases
[3,4].
Leptin, a 167-amino acid sequence protein with structural
similarities to the cytokine family, has been studied exten-
sively in various conditions since its discovery as a satiety
signal in 1994 through positional cloning [5]. It is expressed by
various tissues including adipocytes, liver, placenta, ovaries,
skeletal muscle, pituitary and stomach [6]. Leptin suppresses
food intake and stimulates energy expenditure by interacting
with its receptors in the hypothalamic region of the brain [5].
Also, it is involved in the regulation of immune cells, blood
cells, pancreatic beta cells, muscle, insulin sensitivity and
adipocytes [5,7]. In relation to human disease, leptin has been
associated with diabetes mellitus, reduced bone mass,
atherosclerosis and cancer [3,8e12].
Adiponectin, discovered in the mid-90s by four different
groups, is a 30-kDamonomeric polypeptide of 247 amino acid
residues synthesized by white adipose tissue [5]. It improves
insulin sensitivity and exhibits anti-atherogenic, anti-in-
flammatory and anti-diabetic properties [4,13e15]. High or
low circulating adiponectin levels has been associated with
mortality in apparently healthy elderly cohort [16]. However,
in patients suffering from chronic kidney disease, cardio-
vascular disease or type 2 diabetes, high baseline level ofcirculating adiponectin has been linked to mortality [17e20].
These observations suggest that the exact impact of these
biomolecules depends on their circulating levels and the
underlying health condition of the individual.
The pleiotropic roles of leptin and adiponectin make them
suitable candidates to be studied under varied disease and
health conditions. To this end, leptin and adiponectin have
been studied extensively in chronic non-communicable dis-
eases such as diabetes, cancer and cardiovascular disease
[4,12,18,20]. However, little is known about how these adipo-
cytokines respond to infectious agents such as the Plasmodium
parasite and its consequence to cardiovascular health of the
affected. With sub-Saharan Africa predicted to shoulder the
highest burden of type 2 diabetes mellitus by 2030, it may be
important to examine the role that Plasmodium infection plays
in this context since Africa is responsible formore than 80% of
global malaria burden. Therefore, the current study was un-
dertaken to investigate the effects of Plasmodium falciparum
infection on circulating levels of leptin and adiponectin in
T2DM and non-diabetic controls in relation to measures of
adiposity in a two-year prospective study.Materials and methods
Study site, participants' selection, anthropometry and
laboratory analyses
The study was carried out at Cape Coast Teaching Hospital
(CCTH). CCTH is a referral hospital for the various health fa-
cilities in the Central region with a recognized Diabetic Clinic.
Cape Coast, the capital of the Central region has an estimated
population of 169,894 according to the 2010 Population and
Housing Census. The inhabitants are mainly farmers and
fishermen in the informal sector with a relatively small pro-
portion of the working population in the formal sector. The
metropolis is christened the educational hub of Ghana. Due to
its strategic location, characteristics of individuals who
patronize the services of CCTH reflect those of the entire
region.
One hundred diabetic participants aged 40e80 years were
randomly selected from database of diabetics receiving
appropriate treatments at the CCTH. Controls were age-
matched with the diabetics and were selected from the gen-
eral inhabitants of themetropolis. In all, 200 respondents who
met the inclusion criteria were enrolled for the study. Both
groups of participants were followed over a period of two
years for symptomatic P. falciparum infection. Anthropometric
indices, fasting serum leptin and adiponectin levels were
measured before and during P. falciparum malaria. Details of
sample preparation and storage have been described else-
where [21].
Anthropometric measurements
Weight was measured to the nearest 0.1 kg with height to the
nearest 0.1 cm. Bodymass index was computed as the ratio of
weight in kilogramme to the square of the height in metre (kg/
m2). Weight and height were measured in light clothing
without footwear.
Table 1 eAnthropometric indices, leptin and adiponectin
levels of respondents before malaria.
Index Diabetic
(N ¼ 100)
Non-diabetic
(N ¼ 100)
p-value
WC (cm) 99.06 ± 11.4 92.81 ± 11.3 0.002*
Hip (cm) 105.24 ± 11.31 103.11 ± 11.11 0.343
WHR 0.90 ± 0.07 0.95 ± 0.07 <0.001*
BMI (kg/m2) 28.50 ± 4.65 26.09 ± 5.34 0.025*
Leptin (ng/ml) 21.24 ± 4.07 191.51 ± 24.20 <0.001*
Adiponectin (mg/ml) 2.5 ± 0.31 5.09 ± 0.51 <0.001*
Male respondents
(N ¼ 32) (N ¼ 26)
WC (cm) 91.69 ± 11.24 89.33 ± 10.92 0.409
Hip (cm) 97.61 ± 11.03 96.41 ± 10.90 0.666
WHR 0.86 ± 0.08 0.99 ± 0.09 <0.001*
BMI (kg/m2) 25.50 ± 1.19 24.64 ± 1.19 0.488
Leptin (ng/ml) 7.57 ± 0.50 116.52 ± 23 <0.001*
Adiponectin (mg/ml) 2.36 ± 0.32 4.96 ± 0.12 0.003*
Female respondents
(N¼ 68) (N¼ 74)
WC (cm) 102.85 ± 1.13 93.86 ± 1.14 <0.001*
Hip (cm) 108.59 ± 1.10 105.17 ± 1.13 0.113
WHR 0.92 ± 0.07 0.93 ± 0.06 0.316
BMI (kg/m2) 30.93 ± 1.22 25.94 ± 1.22 <0.001*
Leptin (ng/ml) 38.28 ± 23.33 241.05 ± 22.41 <0.001*
Adiponectin (mg/ml) 2.49 ± 0.21 5.20 ± 0.12 <0.001*
Figures represent mean± standard deviation; Abbreviations: BMI;
body mass index; WHR: waist-to-hip ratio; WC: waist circumfer-
ence; N:number of respondents; *: significant p-value.
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inflexible tape measure at the midpoint between the lower
margin of the last rib and the top of the iliac crest [22]. In terms
of hip circumference, it was measured around the widest
portion of the buttocks.Waist-to-hip ratio was then computed
by dividing waist circumference by the hip circumference.
Laboratory analyses
Serum leptin and adiponectin levels were determined by
commercially available sandwich enzyme-linked immuno-
sorbent assay (ELISA) kits procured from Assaypro, USA
(Assaypro Inc., USA). The detection limits for leptin and adi-
ponectin were 0.12 ng/ml and 0.7 ng/ml respectively. Their
respective inter-assay and intra-assay coefficients of variation
were 4.5% and 7.2% for leptin and 4.3% and 7.2% for
adiponectin.
Malaria diagnosis
Malaria was diagnosed by the CareStart™ Malaria HRP2Pf
rapid diagnostic test (RDT) kit (Access Bio Inc., USA). This RDT
has been assessed comprehensively to be very sensitive and
specific for P. falciparum diagnosis and strongly correlates with
microscopy [23].
Ethical approval
Ethical approval for the study was granted by the Committee
on Human Research, Publications and Ethics of the Kwame
Nkrumah University of Science and Technology, School of
Medical Sciences and Komfo Anokye Teaching Hospital,
Kumasi. The study was conducted in accordance with the
ethical standards of the CCTH and the World Medical Asso-
ciation declaration of Helsinki. In addition, written informed
consent was obtained from all participants.
Data analysis
Data analysis was done by the SPSS software version 17. Re-
sults are presented as mean ± standard deviation (SD). Mean
baseline anthropometric, leptin and adiponectin levels be-
tween study groups or sexes were compared by 2-tailed in-
dependent sample t-test. The mean levels of the measured
parameters before and during malaria were compared across
groups by one-way analysis of variance (ANOVA) with Tukey's
posthoc HSD test. Bivariate correlation, simple and stepwise
linear regression tests were applied. In all analyses, a p-value
<0.05 was considered statistically significant.Results
Baseline anthropometric indices, leptin and adiponectin
levels are depicted in Table 1. Diabetics had significantly
(p < 0.05) higher WC and BMI but lower WHR, baseline leptin
and adiponectin levels (Table 1). Stratification of data by
gender showed that diabetic males had comparable (p > 0.05)
mean WC, hip circumference and BMI but lower (p < 0.05)
baseline mean values for WHR, leptin and adiponectin thantheir control male counterpart (Table 1). With respect to the
female respondents, diabetics exhibited comparablemean hip
circumference and WHR with their non-diabetic female
counterpart but higher BMI and WC (Table 1).
However, mean baseline leptin and adiponectin levels
were lower in diabetic females compared with their non-
diabetic female counterpart (Table 1). In each study group,
the females exhibited higher (p < 0.05) values for all the
measured anthropometric indices than their male counter-
part except BMI which was comparable (p > 0.05) between
genders, andWHR which was lower (p < 0.05) in females than
males in the control group (Figs. 1 and 2). In terms of levels of
adipocytokines, diabetic and non-diabetic females had higher
baseline mean leptin levels than their respective male coun-
terparts but levels of baseline adiponectin were comparable
(Figs. 1 and 2).
In the presence of P. falciparummalaria, mean serum leptin
levels increased appreciably (p < 0.001) to about ten times the
baseline levels for diabetic respondents. In the control group,
malaria-induced mean serum leptin level was almost four
times the mean baseline value (Table 2). Interestingly, the
significantly (p < 0.001) higher levels of leptin and adiponectin
in controls than diabetics seen at baseline could not be
maintained in the presence of falciparum malaria.
Baseline leptin level correlated positively with both WC
(r¼ 0.633; p< 0.001) and BMI (r¼ 0.63; p< 0.001) in diabetics but
only BMI (0.562; p < 0.001) in non-diabetic controls. In addition,
baseline leptin and adiponectin correlated positively
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Fig. 1 e Anthropometric indices and levels of selected adipocytokines in male and female diabetics. Abbreviations: WC: waist
circumference (cm); Hip: hip circumference (cm); WHR: waist-to-hip ratio  102; BMI: body mass index (kg/m2); LPT: leptin ng/
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Fig. 2 e Anthropometric indices and levels of selected adipocytokines in male and female controls. Abbreviations: WC: waist
circumference (cm); Hip: hip circumference (cm); WHR: waist-to-hip ratio  102; BMI: body mass index (kg/m2);
LPT: leptin  10 ng/ml; ADP: adiponectin  101 mg/ml.
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group gender-based analysis of data showed a positive cor-
relation of baseline leptin with BMI (r ¼ 0.539; p < 0.001) and
WC (r ¼ 0.655; p < 0.001) in diabetic females respondents. In
diabetic males, baseline leptin correlated positively with BMI
(r ¼ 0.449, p ¼ 0.028), but adiponectin correlated negatively
with WC (r ¼ 0.58; p ¼ 0.006). In the control group, baseline
leptin correlated positively with BMI in both males (r ¼ 0.658;
p < 0.001) and females (r ¼ 0.466; p < 0.001) but WC (r ¼ 0.489;
p ¼ 0.029) in males only.
In a stepwise regression analysis, BMI and baseline adi-
ponectin emerged as the independent predictors of baseline
leptin levels in non-diabetic respondents with the module
accounting for approximately 45% of the observed variation
(R2 ¼ 0.457, adjusted R2 ¼ 0.445; p < 0.001). With respect to the
diabetic group, BMI was the only significant independent
predictor of baseline leptin level. The module could explain
just 35% of the observed variation (R2 ¼ 0.36, adjusted
R2 ¼ 0.351; p < 0.001) in baseline leptin level.
As expected, the various indices of anthropometry corre-
lated positively with each other with an average correlation
coefficient of 0.8 observed betweenWC and BMI in both study
groups irrespective of malaria.In the presence of malaria, leptin correlated negatively
with adiponectin in non-diabetic controls (r ¼ 0.694;
p < 0.001) only. No association was observed betweenmalaria-
induced leptin or adiponectin levels and the variousmeasures
of anthropometry.Discussion
Three measures of anthropometry were employed in this
study to ascertain the relationship among them and other
measured parameters. The observed trend of higher BMI and
WC for diabetics than control seems to support previous re-
ports that strongly linked higher values of these parameters of
adiposity to T2DM although the specific threshold differed
with population [24e30].
In a large multiracial study to define BMI thresholds above
which T2DM could be diagnosed for different racial groups in
Canada, Chiu et al. reported a value of 26 kg/m2 for re-
spondents of the black race [29]. Despite the acknowledged
probable differences in characteristics between respondents
in the current study and those of Chiu et al., the observed
mean BMI for control respondents in the current study
Table 2eAnalysis of variance comparison ofmean leptin and adiponectin levels of respondents before and duringmalaria.
Parameter Diabetic Non-diabetic F-value p-value
DM
(N ¼ 70)
BM
(N ¼ 100)
DM
(N ¼ 30)
BM
(N ¼ 100)
WC (cm) 99.03± 11.34 99.06 ± 11.41 92.79± 11.36 92.81 ± 11.31 16.58 <0.001*
Hip (cm) 105.19± 11.29 105.24 ± 11.31 103.09± 11.13 103.11 ± 11.11 1.321 0.312
WHR 0.91± 0.05 0.90 ± 0.07 0.94± 0.06 0.95 ± 0.07 9.35 <0.001*
BMI (kg/m2) 27.98 ± 4.53 28.50 ± 4.65 26.01 ± 5.75 26.09 ± 5.34 10.31 0.01*
Leptin (ng/ml) 71.46 ± 7.08 7.57 ± 0.50 64.45 ± 16.17 191.51 ± 24.14 38.94 <0.001*
Adiponectin (mg/ml) 10.70 ± 0.52 2.50 ± 0.31 10.11 ± 0.58 5.09 ± 0.51 494.41 <0.001*
Tukey's HSD DM BM P-value DM BM p-value
WC (cm) 99.03± 11.34 99.06 ± 11.41 0.68 92.79 ± 11.36 92.81 ± 11.31 0.71
Hip (cm) 105.19± 11.29 105.24 ± 11.31 0.72 103.09 ± 11.13 103.11 ± 11.11 0.70
WHR 0.91± 0.05 0.90 ± 0.07 0.47 0.94 ± 0.06 0.95 ± 0.07 0.48
BMI (kg/m2) 27.98 ± 4.53 28.50 ± 4.65 0.42 26.01 ± 5.75 26.09 ± 5.34 0.53
Leptin (ng/ml) 71.46 ± 7.08 7.57 ± 0.50 <0.001* 64.45 ± 16.17 191.51 ± 24.14 <0.001*
Adiponectin (mg/ml) 10.70 ± 0.52 2.50± 0.31 <0.001* 10.11 ± 0.58 5.09 ± 0.51 <0.001*
Figures represent mean ± standard deviation; *: significant p-value; DM: During Malaria; BM: Before Malaria; N: number of respondents;
BMI: body mass index; WHR: waist-to-hip ratio; WC: waist circumference.
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Further stratification of data into gender rather showed that
the mean BMI of the control females was closer to the
threshold than theirmale counterpart although the difference
between them was not significant. With the mean BMI of
diabetic males approaching the 26 kg/m2 threshold, that of
their female counterpart fell within the obesity category as
reported in previous studies [25,31]. This female-related
obesity observed in the current study could be ascribed to
the positive perception of elderly females to weight gain in the
Ghanaian society [32].
Recently, Frank et al. demonstrated that measures of cen-
tral obesity rather than general obesity were strongly linked to
T2DM in the Ghanaian population although the specific index
differed with gender [33]. They observed the strongest asso-
ciation between diabetes and WHR with cutoff values of 0.88
and 0.90 reported for females and males respectively [33].
However, the observed mean WHR for male and female re-
spondents in the present study appears inconsistent with the
gender-specific thresholds reported by Frank et al. [33] This
variation in gender-based WHR values between the current
study and that of Frank et al. could be due to differences in
sample size, age strata and lifestyle of respondents as earlier
reported [33,34].
Interestingly, BMI rather correlated strongly and positively
with WC in the current study in support of earlier reports
[28,35,36]. These measures of adiposity also correlated posi-
tivelywith leptin, an important adipocytokine known to play a
central role in adipose tissue metabolism [5,37]. This positive
association of baseline leptin level with the measures of
adiposity reinforces the adipogenic role of leptin irrespective
of underlying health condition in respondents of the current
study [5].
Leptin is known to circulate at very low levels in lip-
odystrophies but high levels in obese and T2DM individuals
suspected of being resistant to the molecule [38,39]. The
ideal leptin level in humans differs with study, age, gender
and race with consensus on possible reference levels yet tobe reached by the scientific community [40e42]. In the
present study, baseline mean leptin level was higher for
controls than diabetics and in females than the males.
Although the gender-specific variation in leptin level has
been reported and ascribed to gender variation in body
composition, the magnitude of the disparity in the current
study suggests possible additional factors such as treatment
effect [41]. Indeed, the popular anti-diabetic drug, metfor-
min, has long been found to reduce circulating leptin levels
although the extent of reduction may vary with gender [43].
To this end, the huge disparities in baseline leptin levels
between diabetics and controls in the current study could be
ascribed to possible effect of metformin. On the other hand,
the relatively high levels of baseline leptin obtained, espe-
cially, in the control group could be an indication of a
possible leptin resistance reported in the Ghanaian society
[25,44]. This view appears to be further supported by the
positive correlation observed between baseline leptin and
adiponectin in the non-diabetic control group only, sug-
gesting that, the two hormones seem to exhibit positive
feedback relationship instead of the expected negative reg-
ulatory response to each other. In a number of large sample
longitudinal studies, high leptin levels persistently pre-
dicted increased risk of T2DM development in males but not
females, a finding that appears to suggest that males in the
control group of the current study could be at increased risk
of developing T2DM compared to their female counterpart
[45e47]. This relative protection of females from the nega-
tive effect of relative hyperleptinaemia could be due to the
male's higher tendency to develop central obesity compared
with the female's general obesity. With falciparum malaria,
leptin level in diabetics surged almost ten times the baseline
value with that of the controls declining to about 66% of
baseline level. These varied responses to leptin levels of the
two study groups to falciparum malaria may imply varied
consequences for the two groups. Although the observed
increase in leptin level due to malaria in diabetic re-
spondents seems to be in line with a number of
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in leptin levels observed for the non-diabetic controls is at
variance with these studies [48,49]. With hyperleptinaemia
found to be an independent risk factor for stroke and a
predictor of first myocardial infarction, the observed
malaria-induced elevation of serum leptin in diabetic re-
spondents could be suggestive of heightened risk for car-
diovascular disease [50,51]. This finding calls for special
attention to be given to diabetics who get malaria in order to
forestall any cardiovascular incident that may occur. In the
case of the non-diabetic controls, the decline leptin level
observed during malaria could be attributed to possible
suppressive effect of adiponectin as the two hormones
correlated negatively in this study group. This implies that
falciparum malaria seems to rather restore the expected
traditional antagonistic relationship between adiponectin
and leptin in the control respondents [4,5].
Interestingly, a number of studies have associated high
and low levels of adiponectin with diabetes and cardiovas-
cular disease although the specific thresholds differ with
study, ethnicity and race [16,52e54]. In comparison with
published reports, the observed baseline adiponectin levels
were generally low in the current study, corroborating the
finding that blacks generally exhibit low levels of this mole-
cule, due probably, to low expression levels [52,53,55]. As ex-
pected, diabetics recorded much lower values than their non-
diabetic counterpart with no gender-specific variation
observed in the two study groups. Although the observed
trend of baseline adiponectin levels in the two study groups is
in line with those of previous studies, the lack of gender-
specific variation in circulating levels in the current study
appears to deviate from others that reported higher levels for
females [52,53,55e57]. The seeming deviation could be due to
the relatively small number of respondents in the current
study compared with the previous ones. However, baseline
adiponectin exhibited negative correlation with WC only in
the male gender of the diabetic respondents suggesting that,
even in diabetes, the anti-obesity function of adiponectin was
preserved but specific for visceral fat accumulation. In addi-
tion, this observation reiterates the point that gender-specific
variation of adipocytokines must not only be viewed in terms
of circulating levels but their relationship with measures of
adiposity [58].
Interestingly, falciparum malaria elevated drastically,
serum adiponectin levels in both study groups contrary to an
earlier small sample cross-sectional study of Blu¨mer et al.
that did not observe any difference in adiponectin levels
between P. falciparum-infected and uninfected subjects [59].
Work by Teoh et al. on vascular wall revealed a rise adipo-
nectin level in response to vascular injury, an observation
that was explained to indicate advanced atherosclerosis [60].
In addition, a number of recent reports have associated high
levels of adiponectin to all-cause mortality in adults [16,20].
Relating results of the current work to these earlier reports,
the observed elevated adiponectin level in malaria-infected
respondents in the current study could be an indication of
increased risk to cardiovascular event in both groups of re-
spondents, reinforcing the need for diabetics who get ma-
laria to be given the needed attention and swift response
[16,20,60].Conclusion
Falciparum malaria increased adiponectin levels in adult di-
abetics and non-diabetic controls independent of measures of
adiposity. Malaria-induced elevation of leptin level was found
only in the diabetic group. In non-diabetic controls, falciparum
malaria reduced circulating levels of leptin and reversed the
baseline association between leptin and adiponectin. These
observations suggest different mechanisms by which the risk
of cardiovascular event could increase due to malaria in our
study groups.Conflicts of interest
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